Yousif Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.49M Sell
8,798
-600
-6% -$408K 0.06% 293
2026
Q1
$7.26M Sell
9,398
-308
-3% -$236K 0.09% 218
2025
Q4
$7.12M Sell
9,706
-585
-6% -$397K 0.08% 233
2025
Q3
$5.79M Sell
10,291
-576
-5% -$326K 0.06% 280
2025
Q2
$5.71M Sell
10,867
-203
-2% -$113K 0.06% 281
2025
Q1
$7.02M Sell
11,070
-258
-2% -$177K 0.08% 230
2024
Q4
$8.07M Sell
11,328
-1,077
-9% -$904K 0.09% 203
2024
Q3
$13M Buy
12,405
+329
+3% +$366K 0.14% 131
2024
Q2
$12.7M Sell
12,076
-73
-0.6% -$70.8K 0.14% 122
2024
Q1
$11.7M Sell
12,149
-338
-3% -$321K 0.13% 145
2023
Q4
$11M Sell
12,487
-1,584
-11% -$1.3M 0.13% 143
2023
Q3
$11.6M Sell
14,071
-540
-4% -$424K 0.15% 131
2023
Q2
$10.5M Buy
14,611
+315
+2% +$243K 0.13% 150
2023
Q1
$11.7M Sell
14,296
-728
-5% -$549K 0.15% 127
2022
Q4
$10.8M Sell
15,024
-51
-0.3% -$37.6K 0.14% 138
2022
Q3
$10.4M Sell
15,075
-590
-4% -$371K 0.15% 122
2022
Q2
$9.26M Sell
15,665
-1,669
-10% -$1.08M 0.12% 155
2022
Q1
$12.1M Buy
17,334
+155
+0.9% +$98.1K 0.13% 138
2021
Q4
$10.8M Buy
+17,179
New +$10.6M 0.11% 156

Other funds holding REGN

Yousif Capital Management's REGN Position: Q2 2026 in Review

Yousif Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 6.4% in Q2 2026, selling an estimated $408K and leaving 8,798 shares worth $5.49M. The position accounts for 0.06% of the portfolio, ranked #293.

Yousif Capital Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $13M in Q3 2024. 279 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Yousif Capital Management held 8,798 shares of Regeneron Pharmaceuticals worth $5.49M as of Q2 2026.
  • Yousif Capital Management sold 600 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $408K.
  • Regeneron Pharmaceuticals made up 0.06% of Yousif Capital Management's portfolio in Q2 2026, its #293 holding.
  • Yousif Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Regeneron Pharmaceuticals position peaked at $13M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.